U-CNTB

Q:CNTB - CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE - Website unknown - click to update

21:00:38 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
CNTB - Q						0.91	+0.1474	19.3	26.7	17	80	0.8526 1.00 0.8199	3.48 0.5573	17:37:29	Mar 18	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 80

More trades...

Time ET	Ex	Price	Change	Volume
17:37:29	Q	0.901	0.0484	11
16:21:56	Q	0.9001	0.0475	1
15:57:10	Q	0.91	0.0574	100
15:57:10	Q	0.91	0.0574	100
15:57:10	Q	0.91	0.0574	100
15:57:10	Q	0.91	0.0574	100
15:55:06	Q	0.9101	0.0575	30
15:51:08	Q	0.9999	0.1473	45
15:49:30	Q	1.00	0.1474	60
15:47:28	Q	1.00	0.1474	401

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2023-03-18 14:40	U:CNTB	News Release200	Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms
2023-03-17 16:05	U:CNTB	News Release200	Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions
2023-03-06 08:15	U:CNTB	News Release200	Connect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual Meeting

Date ET

Symbol

Type

Headline

2023-03-18 14:40

U:CNTB

News Release

Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms

2023-03-17 16:05

U:CNTB

News Release

Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions

2023-03-06 08:15

U:CNTB

News Release

Connect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual Meeting